Akebia Therapeutics, Inc. (AKBA)

1.625 +0.02 (+0.93%) USD  |  NASDAQ  |  Dec 16, 16:00
1.625 0.00 (0.00%) After-Hours: 16:22
More

Akebia Therapeutics Gross Profit (Annual): 91.34M for Dec. 31, 2024

Gross Profit (Annual) Chart

View Gross Profit (Annual) for AKBA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross Profit Definition

View Gross Profit Definition
Start Trial

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Annual) Range, Past 5 Years

View Gross Profit (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (Annual) Benchmarks

View Gross Profit (Annual) Benchmarks
Start Trial
Pfizer Inc. 41.85B
Ironwood Pharmaceuticals, Inc. 349.40M
Pyxis Oncology, Inc. 12.69M
Karyopharm Therapeutics, Inc. 138.89M
Theravance Biopharma, Inc. 58.37M